Valgene Incorporated dba Cape Drugs

FDA Regulatory Profile

Valgene Incorporated dba Cape Drugs appears in FDA public data with 2 recalls, 0 510(k) clearances, 3 FDA inspections, and 1 compliance action on record. Its most recent recall (D-0284-2022, Class II) was initiated on December 3, 2021.

Summary

Total Recalls
2
510(k) Clearances
0
Inspections
3
Compliance Actions
1

Recent Recalls

NumberClassProductDate
D-0284-2022Class IIB-Complex, injection, 1 mL vials, Rx only, Cape Drugs 1384 Cape St. Claire Road Annapolis, MD 21409December 3, 2021
D-0283-2022Class IIMethylcobalamin 12mg/ml injection, 1 mL vials, Rx only, Cape Drugs 1384 Cape St. Claire Road AnnapoDecember 3, 2021